The FDA has granted Mylan Laboratories final approval to market its version of Otsuka Pharmaceutical's blood circulation drug Pletal.
Mylan will market the drug in 50- and 100-mg tablets and said it will begin shipping the product immediately.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing